Capastat and diarrhoea Patient Reports February 13, 2012

Capastat Side Effects Report #5253420-X
Capastat side effect was reported by a Physician from SOUTH AFRICA on Feb 16, 2007. Male patient, 57 years of age, weighting 83.78 lb, was diagnosed with tuberculosis  and was treated with Capastat. After drug was administered, patient experienced the following side effects: diarrhoea, hypokalaemia, vomiting. Capastat dosage: 750 MG, 5/W. During the same period patient was treated with PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, ETHIONAMIDE, OFLOXACIN, TERIZIDONE, KANAMYCIN. Patient died on 01/20/2007.

Capastat Side Effects Report #5273942-5
Capastat side effect was reported by a Physician from SOUTH AFRICA on Mar 15, 2007. Male patient, 57 years of age, weighting 83.78 lb, was diagnosed with tuberculosis  and was treated with Capastat. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood bilirubin increased, blood chloride decreased, blood creatinine increased, blood potassium decreased, diarrhoea, hypokalaemia, protein total decreased. Capastat dosage: 750 MG, 5/W. During the same period patient was treated with PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, ETHIONAMIDE, OFLOXACIN, TERIZIDONE, KANAMYCIN. Patient died on 01/20/2007.

Capastat Side Effects Report #5281975-8
Capastat side effect was reported by a Physician from SOUTH AFRICA on Mar 15, 2007. Male patient, 57 years of age, weighting 83.78 lb, was diagnosed with tuberculosis  and was treated with Capastat. After drug was administered, patient experienced the following side effects: diarrhoea, hypokalaemia, vomiting. Capastat dosage: 750 MG, 5/W. During the same period patient was treated with PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, ETHIONAMIDE, OFLOXACIN, TERIZIDONE, KANAMYCIN. Patient died on 01/20/2007.

Capastat Side Effects Report #5802581-X
Capastat side effect was reported by a Consumer or non-health professional from SOUTH AFRICA on June 24, 2008. Female patient, weighting 83.78 lb, was diagnosed with tuberculosis  and was treated with Capastat. After drug was administered, patient experienced the following side effects: diarrhoea, hyperkalaemia, renal failure acute. Capastat dosage: 500 MG, DAILY (1/D). During the same period patient was treated with TERIZIDONE, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE, ETHIONAMIDE, COTRIMOXAZOLE, VITAMINS. Patient was hospitalized. Patient died on 01/25/2008.